company background image
A199800 logo

ToolGen KOSDAQ:A199800 Stock Report

Last Price

₩68.20k

Market Cap

₩540.7b

7D

-29.8%

1Y

43.6%

Updated

28 Mar, 2024

Data

Company Financials

ToolGen Incorporated

KOSDAQ:A199800 Stock Report

Market Cap: ₩540.7b

A199800 Stock Overview

ToolGen Incorporated, a biotechnology company, focuses on the development of genome editing technology in South Korea.

A199800 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

ToolGen Incorporated Competitors

Price History & Performance

Summary of all time highs, changes and price drops for ToolGen
Historical stock prices
Current Share Price₩68,200.00
52 Week High₩110,000.00
52 Week Low₩26,100.00
Beta1.91
1 Month Change35.32%
3 Month Change-2.85%
1 Year Change43.58%
3 Year Change-34.17%
5 Year Change-28.51%
Change since IPO39.18%

Recent News & Updates

Recent updates

Shareholder Returns

A199800KR BiotechsKR Market
7D-29.8%1.4%2.4%
1Y43.6%21.6%12.2%

Return vs Industry: A199800 exceeded the KR Biotechs industry which returned 21.6% over the past year.

Return vs Market: A199800 exceeded the KR Market which returned 12.2% over the past year.

Price Volatility

Is A199800's price volatile compared to industry and market?
A199800 volatility
A199800 Average Weekly Movement18.0%
Biotechs Industry Average Movement8.0%
Market Average Movement5.2%
10% most volatile stocks in KR Market11.9%
10% least volatile stocks in KR Market2.4%

Stable Share Price: A199800's share price has been volatile over the past 3 months.

Volatility Over Time: A199800's weekly volatility (18%) has been stable over the past year, but is still higher than 75% of KR stocks.

About the Company

FoundedEmployeesCEOWebsite
199983Young Ho Kimhttps://www.toolgen.com

ToolGen Incorporated, a biotechnology company, focuses on the development of genome editing technology in South Korea. The company develops clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 gene scissors for gene editing in eukaryotic cells. It is involved in patent monetization, treatment, and seed businesses.

ToolGen Incorporated Fundamentals Summary

How do ToolGen's earnings and revenue compare to its market cap?
A199800 fundamental statistics
Market cap₩540.67b
Earnings (TTM)-₩42.34b
Revenue (TTM)₩1.10b

490.0x

P/S Ratio

-12.8x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A199800 income statement (TTM)
Revenue₩1.10b
Cost of Revenue₩196.62m
Gross Profit₩906.79m
Other Expenses₩43.25b
Earnings-₩42.34b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-5.34k
Gross Margin82.18%
Net Profit Margin-3,837.21%
Debt/Equity Ratio0%

How did A199800 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.